John T Kanegaye

Summary

Affiliation: Rady Children's Hospital
Country: USA

Publications

  1. pmc Recognition of a Kawasaki disease shock syndrome
    John T Kanegaye
    Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California, USA
    Pediatrics 123:e783-9. 2009
  2. doi request reprint Diagnostic value of immature neutrophils (bands) in the cerebrospinal fluid of children with cerebrospinal fluid pleocytosis
    John T Kanegaye
    Division of Emergency Medicine, Rady Children s Hospital San Diego, 3020 Children s Way, MC 5075, San Diego, CA 92123, USA
    Pediatrics 123:e967-71. 2009
  3. pmc Cardiovascular biomarkers in acute Kawasaki disease
    Yuichiro Z Sato
    Department of Pediatrics and Medicine, Rady Children s Hospital, University of California San Diego, School of Medicine, La Jolla, CA, United States
    Int J Cardiol 164:58-63. 2013
  4. ncbi request reprint Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial
    Adriana H Tremoulet
    Department of Pediatrics, University of California San Diego, La Jolla, CA, USA Rady Children s Hospital San Diego, San Diego, CA, USA Electronic address
    Lancet 383:1731-8. 2014
  5. doi request reprint Specificity of regulatory T cells that modulate vascular inflammation
    Alessandra Franco
    Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, CA, USA and
    Autoimmunity 47:95-104. 2014
  6. pmc Pyuria associated with acute Kawasaki disease and fever from other causes
    Hiroko Shike
    Department of Pediatrics, University of California, San Diego School of Medicine, La Jolla, CA 92093 0641, USA
    Pediatr Infect Dis J 28:440-3. 2009
  7. pmc Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease
    John T Kanegaye
    Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, CA, USA
    J Pediatr 162:1259-63, 1263.e1-2. 2013
  8. pmc A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses
    Xuefeng B Ling
    Department of Pediatrics, Stanford University, Stanford, CA 94305, USA
    BMC Med 9:130. 2011
  9. ncbi request reprint Oral analgesia before pediatric ketamine sedation is not associated with an increased risk of emesis and other adverse events
    Michele R McKee
    Department of Pediatrics, University of California San Diego, San Diego, California 92123, USA
    J Emerg Med 35:23-8. 2008
  10. pmc Differential expression of miR-145 in children with Kawasaki disease
    Chisato Shimizu
    Department of Pediatrics, University of California San Diego, La Jolla, California, USA
    PLoS ONE 8:e58159. 2013

Collaborators

Detail Information

Publications16

  1. pmc Recognition of a Kawasaki disease shock syndrome
    John T Kanegaye
    Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California, USA
    Pediatrics 123:e783-9. 2009
    ..We sought to define the characteristics that distinguish Kawasaki disease shock syndrome from hemodynamically normal Kawasaki disease...
  2. doi request reprint Diagnostic value of immature neutrophils (bands) in the cerebrospinal fluid of children with cerebrospinal fluid pleocytosis
    John T Kanegaye
    Division of Emergency Medicine, Rady Children s Hospital San Diego, 3020 Children s Way, MC 5075, San Diego, CA 92123, USA
    Pediatrics 123:e967-71. 2009
    ..We evaluated the diagnostic utility of the presence and number of cerebrospinal fluid (CSF) bands in distinguishing bacterial from aseptic meningitis among children with CSF pleocytosis...
  3. pmc Cardiovascular biomarkers in acute Kawasaki disease
    Yuichiro Z Sato
    Department of Pediatrics and Medicine, Rady Children s Hospital, University of California San Diego, School of Medicine, La Jolla, CA, United States
    Int J Cardiol 164:58-63. 2013
    ..Endomycocardial biopsies have demonstrated that subclinical myocarditis is a universal feature of acute Kawasaki disease (KD)...
  4. ncbi request reprint Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial
    Adriana H Tremoulet
    Department of Pediatrics, University of California San Diego, La Jolla, CA, USA Rady Children s Hospital San Diego, San Diego, CA, USA Electronic address
    Lancet 383:1731-8. 2014
    ..We assessed whether the addition of infliximab to standard therapy (intravenous immunoglobulin and aspirin) in acute Kawasaki disease reduces the rate of treatment resistance...
  5. doi request reprint Specificity of regulatory T cells that modulate vascular inflammation
    Alessandra Franco
    Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, CA, USA and
    Autoimmunity 47:95-104. 2014
    ..Our results point to a specificity of a previously un-described Treg population for the clinical benefit provided by IVIG therapy in children...
  6. pmc Pyuria associated with acute Kawasaki disease and fever from other causes
    Hiroko Shike
    Department of Pediatrics, University of California, San Diego School of Medicine, La Jolla, CA 92093 0641, USA
    Pediatr Infect Dis J 28:440-3. 2009
    ..Overall, the presence of pyuria was neither specific nor sensitive as a marker for KD, but the magnitude of pyuria was significantly higher in KD patients compared with the FC group...
  7. pmc Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease
    John T Kanegaye
    Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, CA, USA
    J Pediatr 162:1259-63, 1263.e1-2. 2013
    ..To identify characteristics differentiating the node-first presentation of Kawasaki disease (NFKD) from bacterial cervical lymphadenitis (BCL) and typical Kawasaki disease (KD)...
  8. pmc A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses
    Xuefeng B Ling
    Department of Pediatrics, Stanford University, Stanford, CA 94305, USA
    BMC Med 9:130. 2011
    ..We sought to develop a diagnostic algorithm to help clinicians distinguish Kawasaki disease patients from febrile controls to allow timely initiation of treatment...
  9. ncbi request reprint Oral analgesia before pediatric ketamine sedation is not associated with an increased risk of emesis and other adverse events
    Michele R McKee
    Department of Pediatrics, University of California San Diego, San Diego, California 92123, USA
    J Emerg Med 35:23-8. 2008
    ..6%, difference in proportions -0.6% [95% CI -4.7% to 3.9%]). No association was found between administration of oral analgesia before procedural sedation and anesthesia and the frequency of emesis or other adverse events...
  10. pmc Differential expression of miR-145 in children with Kawasaki disease
    Chisato Shimizu
    Department of Pediatrics, University of California San Diego, La Jolla, California, USA
    PLoS ONE 8:e58159. 2013
    ..To understand the role that microRNAs play in modifying gene expression in Kawasaki disease, we studied microRNAs from whole blood during the acute and convalescent stages of the illness...
  11. pmc Screening for adolescent anxiety disorders in a pediatric emergency department
    Holly J Ramsawh
    Department of Psychiatry, University of California, San Diego, La Jolla, CA 92093 0855, USA
    Pediatr Emerg Care 28:1041-7. 2012
    ..Scant data exist on adolescent anxiety in emergency department (ED) settings. We sought to characterize select clinical characteristics and health care use associated with anxiety disorders in a pediatric ED...
  12. pmc Treatment response in kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G
    Shohei Ogata
    Department of Pediatrics, University of California San Diego, School of Medicine, La Jolla, California, United States of America
    PLoS ONE 8:e81448. 2013
    ..We asked whether IVIG failures correlated with levels of α2-6Sia on infused IVIG or on the patient's own endogenous IgG...
  13. doi request reprint Rapid medical assessment: improving pediatric emergency department time to provider, length of stay, and left without being seen rates
    Virginia W Tsai
    Department of Emergency Medicine, University of California, Davis, Sacramento, CA 95817, USA
    Pediatr Emerg Care 28:354-6. 2012
    ..RMA is designed to evaluate and discharge uncomplicated patients quickly or initiate diagnostic workup and treatment before the patient is placed in an ED bed...
  14. doi request reprint Ibuprofen provides analgesia equivalent to acetaminophen-codeine in the treatment of acute pain in children with extremity injuries: a randomized clinical trial
    Janet H Friday
    Department of Pediatrics, University of California San Diego, La Jolla, CA, USA
    Acad Emerg Med 16:711-6. 2009
    ....
  15. ncbi request reprint Ketamine-propofol combination sedation for fracture reduction in the pediatric emergency department
    Ghazala Q Sharieff
    Division of Emergency Medicine, Rady Children s Hospital and Health Center, 3020 Children s Way MC 5075, San Diego, CA 92123 4282, USA
    Pediatr Emerg Care 23:881-4. 2007
    ..To evaluate the time of onset and recovery from and the efficacy and safety of intravenous ketamine-propofol sedation for reduction of forearm fractures in the pediatric emergency department setting...
  16. ncbi request reprint Adenovirus, adeno-associated virus and Kawasaki disease
    Hiroko Shike
    Department of Pediatrics, University of California San Diego School of Medicine, San Diego, CA, USA
    Pediatr Infect Dis J 24:1011-4. 2005
    ..No evidence was found to suggest a link between either virus and Kawasaki disease...